Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thalassemia | 19 | 2020 | 144 | 9.84 | Why? |
| beta-Thalassemia | 17 | 2021 | 200 | 8.30 | Why? |
| Iron Overload | 13 | 2021 | 113 | 5.09 | Why? |
| Iron Chelating Agents | 10 | 2021 | 79 | 4.92 | Why? |
| Myelodysplastic Syndromes | 4 | 2018 | 261 | 2.31 | Why? |
| Anemia, Iron-Deficiency | 5 | 2018 | 210 | 1.61 | Why? |
| Erythropoiesis | 6 | 2018 | 71 | 1.53 | Why? |
| Fetal Hemoglobin | 2 | 2018 | 22 | 1.49 | Why? |
| Chelation Therapy | 5 | 2021 | 32 | 1.49 | Why? |
| Deferoxamine | 2 | 2018 | 22 | 1.38 | Why? |
| Blood Transfusion | 15 | 2020 | 1399 | 1.23 | Why? |
| Benzoates | 2 | 2017 | 102 | 1.23 | Why? |
| Lebanon | 9 | 2021 | 557 | 1.22 | Why? |
| Iron | 7 | 2018 | 619 | 1.17 | Why? |
| Carcinoma, Hepatocellular | 4 | 2018 | 1222 | 1.12 | Why? |
| Thiazoles | 2 | 2018 | 496 | 0.99 | Why? |
| Triazoles | 2 | 2017 | 440 | 0.94 | Why? |
| Siderophores | 2 | 2017 | 12 | 0.92 | Why? |
| Explosions | 1 | 2020 | 42 | 0.85 | Why? |
| Transfusion Medicine | 1 | 2021 | 101 | 0.79 | Why? |
| Hemoglobinopathies | 1 | 2020 | 90 | 0.79 | Why? |
| beta-Globins | 1 | 2018 | 8 | 0.78 | Why? |
| Liver Neoplasms | 4 | 2018 | 1666 | 0.78 | Why? |
| Thrombophilia | 4 | 2021 | 1935 | 0.74 | Why? |
| Anemia | 5 | 2018 | 789 | 0.73 | Why? |
| Dalteparin | 1 | 2018 | 57 | 0.73 | Why? |
| Cyclohexanones | 1 | 2017 | 9 | 0.73 | Why? |
| Dihydropyridines | 1 | 2017 | 29 | 0.71 | Why? |
| Health Planning Guidelines | 1 | 2018 | 133 | 0.70 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.68 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 139 | 0.68 | Why? |
| Codon | 1 | 2018 | 287 | 0.68 | Why? |
| Hydroxyurea | 1 | 2017 | 87 | 0.67 | Why? |
| Genetic Loci | 1 | 2018 | 439 | 0.66 | Why? |
| Rare Diseases | 1 | 2020 | 373 | 0.62 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.60 | Why? |
| Blood Safety | 1 | 2021 | 459 | 0.59 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2017 | 114 | 0.58 | Why? |
| Economic Recession | 1 | 2020 | 453 | 0.58 | Why? |
| Carbamates | 1 | 2018 | 485 | 0.57 | Why? |
| Magnetic Resonance Imaging | 5 | 2018 | 6551 | 0.57 | Why? |
| Anemia, Sickle Cell | 2 | 2020 | 546 | 0.55 | Why? |
| Hematologic Diseases | 2 | 2020 | 614 | 0.54 | Why? |
| Knowledge | 1 | 2018 | 452 | 0.54 | Why? |
| Sofosbuvir | 1 | 2018 | 518 | 0.53 | Why? |
| Hematologic Neoplasms | 2 | 2017 | 2105 | 0.51 | Why? |
| Gastrointestinal Neoplasms | 1 | 2018 | 392 | 0.50 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.49 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.47 | Why? |
| Ferritins | 2 | 2017 | 2055 | 0.44 | Why? |
| Back Pain | 1 | 2012 | 115 | 0.43 | Why? |
| Pyridones | 2 | 2018 | 738 | 0.42 | Why? |
| Vascular Diseases | 2 | 2017 | 846 | 0.39 | Why? |
| Splenectomy | 2 | 2021 | 85 | 0.39 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.38 | Why? |
| Spine | 1 | 2012 | 292 | 0.38 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.38 | Why? |
| Spinal Diseases | 1 | 2012 | 238 | 0.37 | Why? |
| Tertiary Care Centers | 4 | 2021 | 8248 | 0.36 | Why? |
| Disease Management | 9 | 2021 | 6841 | 0.34 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.34 | Why? |
| Politics | 1 | 2020 | 1824 | 0.33 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.30 | Why? |
| Anemia, Diamond-Blackfan | 1 | 2004 | 3 | 0.30 | Why? |
| Liver | 2 | 2018 | 4007 | 0.30 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.30 | Why? |
| Arrhythmias, Cardiac | 2 | 2019 | 2510 | 0.30 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.29 | Why? |
| Humans | 58 | 2021 | 930598 | 0.29 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.27 | Why? |
| Hematopoiesis, Extramedullary | 1 | 2003 | 9 | 0.27 | Why? |
| Valproic Acid | 1 | 2004 | 114 | 0.26 | Why? |
| Thromboembolism | 1 | 2017 | 2101 | 0.26 | Why? |
| Spinal Cord Compression | 1 | 2003 | 35 | 0.26 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.26 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.26 | Why? |
| Venous Thrombosis | 1 | 2018 | 2739 | 0.25 | Why? |
| Egypt | 2 | 2017 | 1211 | 0.24 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.24 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.23 | Why? |
| Activin Receptors, Type II | 1 | 2021 | 20 | 0.23 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.22 | Why? |
| Phosphodiesterase Inhibitors | 1 | 2021 | 61 | 0.22 | Why? |
| Inflammatory Bowel Diseases | 2 | 2017 | 3209 | 0.21 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.21 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.21 | Why? |
| Kidney Failure, Chronic | 1 | 2016 | 3222 | 0.20 | Why? |
| Female | 25 | 2021 | 380317 | 0.20 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.20 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.20 | Why? |
| Quality of Life | 6 | 2018 | 9820 | 0.20 | Why? |
| Anticonvulsants | 1 | 2004 | 634 | 0.19 | Why? |
| Acute Chest Syndrome | 1 | 2020 | 140 | 0.19 | Why? |
| Hemoglobins | 3 | 2019 | 958 | 0.19 | Why? |
| Transfusion Reaction | 2 | 2018 | 245 | 0.19 | Why? |
| Population | 1 | 2018 | 114 | 0.18 | Why? |
| Male | 22 | 2021 | 367725 | 0.18 | Why? |
| Combined Modality Therapy | 2 | 2018 | 3395 | 0.18 | Why? |
| Tablets, Enteric-Coated | 1 | 2017 | 6 | 0.17 | Why? |
| Adult | 17 | 2021 | 244371 | 0.17 | Why? |
| Common Bile Duct | 1 | 2017 | 21 | 0.17 | Why? |
| Choledocholithiasis | 1 | 2017 | 33 | 0.17 | Why? |
| Drug Administration Routes | 1 | 2017 | 106 | 0.17 | Why? |
| Erythroid Cells | 1 | 2017 | 82 | 0.17 | Why? |
| Abortion, Habitual | 1 | 2017 | 35 | 0.17 | Why? |
| Social Change | 1 | 2020 | 303 | 0.17 | Why? |
| Practice Guidelines as Topic | 3 | 2018 | 15421 | 0.17 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.16 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.16 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.16 | Why? |
| Erythrocyte Indices | 1 | 2018 | 207 | 0.16 | Why? |
| Obstetric Labor, Premature | 1 | 2017 | 114 | 0.15 | Why? |
| Recombinant Fusion Proteins | 1 | 2021 | 919 | 0.15 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.15 | Why? |
| Chemistry, Pharmaceutical | 1 | 2017 | 152 | 0.15 | Why? |
| Pain | 2 | 2021 | 1084 | 0.15 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.15 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.15 | Why? |
| Birth Weight | 1 | 2017 | 250 | 0.15 | Why? |
| Liver Diseases | 3 | 2020 | 2698 | 0.14 | Why? |
| Middle Aged | 15 | 2018 | 270681 | 0.13 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.13 | Why? |
| Cardiomyopathies | 2 | 2020 | 997 | 0.13 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.13 | Why? |
| Women's Health | 1 | 2018 | 444 | 0.12 | Why? |
| Nitriles | 1 | 2017 | 1053 | 0.12 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.12 | Why? |
| Bone Remodeling | 1 | 2012 | 59 | 0.12 | Why? |
| North America | 1 | 2017 | 1400 | 0.12 | Why? |
| Intervertebral Disc Degeneration | 1 | 2012 | 31 | 0.12 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.12 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.12 | Why? |
| Hematology | 1 | 2018 | 649 | 0.11 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.11 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.11 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.11 | Why? |
| Diphosphonates | 1 | 2012 | 121 | 0.11 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.11 | Why? |
| Dietary Supplements | 2 | 2021 | 2251 | 0.11 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.11 | Why? |
| Abortion, Spontaneous | 1 | 2017 | 776 | 0.11 | Why? |
| Osteoporosis | 2 | 2018 | 410 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.10 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.10 | Why? |
| Standard of Care | 1 | 2017 | 1297 | 0.10 | Why? |
| Bone Density Conservation Agents | 1 | 2012 | 209 | 0.10 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.10 | Why? |
| Young Adult | 6 | 2018 | 93724 | 0.10 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.09 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.09 | Why? |
| Child | 5 | 2021 | 70012 | 0.09 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Taiwan | 1 | 2017 | 2556 | 0.09 | Why? |
| beta-Glucosidase | 1 | 2007 | 7 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Health Status Indicators | 1 | 2011 | 341 | 0.09 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.08 | Why? |
| Pyrazoles | 1 | 2017 | 1791 | 0.08 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.08 | Why? |
| Gaucher Disease | 1 | 2007 | 63 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.08 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Laparoscopy | 1 | 2017 | 1532 | 0.07 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.07 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.07 | Why? |
| Cardiovascular Diseases | 2 | 2021 | 11497 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Leukemia, Prolymphocytic | 1 | 2003 | 10 | 0.07 | Why? |
| Educational Status | 1 | 2011 | 1451 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Leukemia, B-Cell | 1 | 2003 | 50 | 0.07 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.07 | Why? |
| Heart Diseases | 2 | 2018 | 3503 | 0.07 | Why? |
| Heparin | 1 | 2017 | 2600 | 0.07 | Why? |
| Symptom Assessment | 1 | 2018 | 4967 | 0.07 | Why? |
| Antigens, CD20 | 1 | 2003 | 105 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.06 | Why? |
| Social Class | 1 | 2011 | 1360 | 0.06 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.06 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.06 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.06 | Why? |
| Aged | 6 | 2018 | 215776 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.06 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Animals | 3 | 2018 | 78931 | 0.05 | Why? |
| Erythrocyte Transfusion | 1 | 2003 | 386 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Heart Function Tests | 1 | 2019 | 101 | 0.05 | Why? |
| Pseudoxanthoma Elasticum | 1 | 2018 | 9 | 0.05 | Why? |
| Femur Head Necrosis | 1 | 2018 | 25 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2017 | 88759 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Erythroid Precursor Cells | 1 | 2017 | 39 | 0.04 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Prednisolone | 1 | 2021 | 443 | 0.04 | Why? |
| Retrospective Studies | 3 | 2017 | 105322 | 0.04 | Why? |
| Bone Diseases | 1 | 2017 | 101 | 0.04 | Why? |
| Joint Diseases | 1 | 2018 | 122 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Connective Tissue Diseases | 1 | 2018 | 187 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.04 | Why? |
| Endocrine System Diseases | 1 | 2017 | 282 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Arthritis | 1 | 2018 | 288 | 0.03 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Italy | 1 | 2017 | 38444 | 0.03 | Why? |
| Myalgia | 1 | 2018 | 1015 | 0.03 | Why? |
| Fractures, Bone | 1 | 2018 | 487 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| United States | 1 | 2018 | 46150 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.02 | Why? |
| Mutation | 1 | 2007 | 12376 | 0.02 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.02 | Why? |
| Pedigree | 1 | 2007 | 502 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Gene Rearrangement | 1 | 2003 | 84 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.02 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Amino Acid Substitution | 1 | 2007 | 1706 | 0.01 | Why? |
| Remission Induction | 1 | 2003 | 950 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |